181 related articles for article (PubMed ID: 24402721)
1. Whole-body magnetic resonance imaging (WB-MRI) as surveillance for subsequent malignancies in survivors of hereditary retinoblastoma: a pilot study.
Friedman DN; Lis E; Sklar CA; Oeffinger KC; Reppucci M; Fleischut MH; Francis JH; Marr B; Abramson DH; Dunkel IJ
Pediatr Blood Cancer; 2014 Aug; 61(8):1440-4. PubMed ID: 24402721
[TBL] [Abstract][Full Text] [Related]
2. Whole-body magnetic resonance imaging as surveillance for subsequent malignancies in preadolescent, adolescent, and young adult survivors of germline retinoblastoma: An update.
Friedman DN; Hsu M; Moskowitz CS; Francis JH; Lis E; Fleischut MH; Oeffinger KC; Walsh M; Tonorezos ES; Sklar CA; Abramson DH; Dunkel IJ
Pediatr Blood Cancer; 2020 Jul; 67(7):e28389. PubMed ID: 32386119
[TBL] [Abstract][Full Text] [Related]
3. Does the Clinical Presentation of Secondary Osteosarcoma in Patients Who Survive Retinoblastoma Differ From That of Conventional Osteosarcoma and How Do We Detect Them?
Kim Y; Park JW; Cho HS; Jang WY; Han I; Kim HS
Clin Orthop Relat Res; 2023 Nov; 481(11):2154-2163. PubMed ID: 37145140
[TBL] [Abstract][Full Text] [Related]
4. Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy.
Wong JR; Morton LM; Tucker MA; Abramson DH; Seddon JM; Sampson JN; Kleinerman RA
J Clin Oncol; 2014 Oct; 32(29):3284-90. PubMed ID: 25185089
[TBL] [Abstract][Full Text] [Related]
5. Subsequent malignant neoplasms in the pediatric age in retinoblastoma survivors in Argentina.
Villanueva G; Sampor C; Moreno F; Alderete D; Moresco A; Pinto N; Szijan I; Schaiquevich P; Felice MS; Rose A; Zubizarreta P; Sgroi M; Fandiño A; Chantada G
Pediatr Blood Cancer; 2022 Aug; 69(8):e29710. PubMed ID: 35451226
[TBL] [Abstract][Full Text] [Related]
6. Pineal cysts-A benign association with familial retinoblastoma.
Gupta AK; Jones M; Prelog K; Bui J; Zhu J; Ng A; Dalla-Pozza L
Pediatr Hematol Oncol; 2016 Sep; 33(6):408-414. PubMed ID: 27689687
[TBL] [Abstract][Full Text] [Related]
7. Second malignant neoplasms following chemoreduction with carboplatin, etoposide, and vincristine in 245 patients with intraocular retinoblastoma.
Turaka K; Shields CL; Meadows AT; Leahey A
Pediatr Blood Cancer; 2012 Jul; 59(1):121-5. PubMed ID: 21826785
[TBL] [Abstract][Full Text] [Related]
8. Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study.
Friedman DN; Chou JF; Oeffinger KC; Kleinerman RA; Ford JS; Sklar CA; Li Y; McCabe MS; Robison LL; Marr BP; Abramson DH; Dunkel IJ
Cancer; 2016 Mar; 122(5):773-81. PubMed ID: 26755259
[TBL] [Abstract][Full Text] [Related]
9. Second cranio-facial malignancies in hereditary retinoblastoma survivors previously treated with radiation therapy: clinic and radiologic characteristics and survival outcomes.
Rodjan F; Graaf Pd; Brisse HJ; Verbeke JI; Sanchez E; Galluzzi P; Göricke S; Maeder P; Aerts I; Dendale R; Desjardins L; de Franscesco S; Bornfeld N; Sauerwein W; Popovic MB; Knol DL; Moll AC; Castelijns JA
Eur J Cancer; 2013 May; 49(8):1939-47. PubMed ID: 23415887
[TBL] [Abstract][Full Text] [Related]
10. Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study.
O'Neill AF; Voss SD; Jagannathan JP; Kamihara J; Nibecker C; Itriago-Araujo E; Masciari S; Parker E; Barreto M; London WB; Garber JE; Diller L
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29077256
[TBL] [Abstract][Full Text] [Related]
11. Second primary osteosarcomas in patients with retinoblastoma.
Fujiwara T; Fujiwara M; Numoto K; Ogura K; Yoshida A; Yonemoto T; Suzuki S; Kawai A
Jpn J Clin Oncol; 2015 Dec; 45(12):1139-45. PubMed ID: 26438540
[TBL] [Abstract][Full Text] [Related]
12. Secondary malignant neoplasms among children, adolescents, and young adults with osteosarcoma.
Lee JS; DuBois SG; Boscardin WJ; Wustrack RL; Goldsby RE
Cancer; 2014 Dec; 120(24):3987-93. PubMed ID: 25116228
[TBL] [Abstract][Full Text] [Related]
13. Correlation between RB1germline mutations and second primary malignancies in hereditary retinoblastoma patients treated with external beam radiotherapy.
Chaussade A; Millot G; Wells C; Brisse H; Laé M; Savignoni A; Desjardins L; Dendale R; Doz F; Aerts I; Jimenez I; Cassoux N; Stoppa Lyonnet D; Gauthier Villars M; Houdayer C
Eur J Med Genet; 2019 Mar; 62(3):217-223. PubMed ID: 30031154
[TBL] [Abstract][Full Text] [Related]
14. Magnetic Resonance Imaging Screening for Trilateral Retinoblastoma: The Memorial Sloan Kettering Cancer Center Experience 2006-2016.
Qureshi S; Francis JH; Haque SS; Dunkel IJ; Souweidane MM; Friedman DN; Abramson DH
Ophthalmol Retina; 2020 Mar; 4(3):327-335. PubMed ID: 31948910
[TBL] [Abstract][Full Text] [Related]
15. Long-term medical outcomes in survivors of extra-ocular retinoblastoma: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.
Friedman DN; Sklar CA; Oeffinger KC; Kernan NA; Khakoo Y; Marr BP; Wolden SL; Abramson DH; Dunkel IJ
Pediatr Blood Cancer; 2013 Apr; 60(4):694-9. PubMed ID: 22911631
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcome of osteosarcoma after bilateral retinoblastoma: a retrospective study of eight cases.
Lee JA; Choi SY; Kang HJ; Lee JW; Kim H; Kim JH; Sung KW; Shin HY; Ahn HS; Park KD
Br J Ophthalmol; 2014 Oct; 98(10):1355-9. PubMed ID: 24795337
[TBL] [Abstract][Full Text] [Related]
17. Long-term risk of subsequent cancer incidence among hereditary and nonhereditary retinoblastoma survivors.
Schonfeld SJ; Kleinerman RA; Abramson DH; Seddon JM; Tucker MA; Morton LM
Br J Cancer; 2021 Mar; 124(7):1312-1319. PubMed ID: 33473166
[TBL] [Abstract][Full Text] [Related]
18. Benign Tumors in Long-Term Survivors of Retinoblastoma.
van Hoefen Wijsard M; Schonfeld SJ; van Leeuwen FE; Moll AC; Fabius AW; Abramson DH; Seddon JM; Francis JH; Tucker MA; Kleinerman RA; Morton LM
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33917779
[TBL] [Abstract][Full Text] [Related]
19. Risk of Second Tumors in Retinoblastoma Survivors after Ionizing Radiation: A Review.
Figueiredo D; Marques IA; Pires AS; Cavaleiro CF; Costa LC; Castela G; Murta JN; Botelho MF; Abrantes AM
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001596
[TBL] [Abstract][Full Text] [Related]
20. Whole body magnetic resonance imaging (WB-MRI) and brain MRI baseline surveillance in TP53 germline mutation carriers: experience from the Li-Fraumeni Syndrome Education and Early Detection (LEAD) clinic.
Bojadzieva J; Amini B; Day SF; Jackson TL; Thomas PS; Willis BJ; Throckmorton WR; Daw NC; Bevers TB; Strong LC
Fam Cancer; 2018 Apr; 17(2):287-294. PubMed ID: 28988289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
